Clinical Chemistry
Quality Assurance
CC-QAQuality assurance is everything the laboratory does so that it can say a result is trustworthy before anyone acts on it. In clinical chemistry that means control and calibration data read properly, proficiency specimens treated exactly like patient specimens, records and documents that survive an audit, reagents verified and in stock, and problems written down rather than quietly fixed. Nothing in this domain generates a result on its own, yet a failure anywhere in it makes every result the laboratory reports questionable. Quality Assurance is one of the eight competency areas assessed in the Clinical Chemistry Fields-of-Practice examination set by CAMLPR.
Running external survey specimens as though they were patients
External quality assessment shows how your laboratory performs against its peers on identical material. You are expected to treat a survey specimen exactly as you would a patient specimen: routine method, routine staff, routine run, no extra repeats that would never happen on a real request, and no comparing of results with another laboratory before the submission deadline. When the report comes back you review every analyte, decide whether an unacceptable result reflects a genuine method problem, investigate it, document what you found and record the corrective action taken.
A technologist is completing a proficiency testing survey for serum potassium and is uneasy about one of the specimens. Before the submission deadline she telephones a technologist at a neighbouring hospital to compare their values. Which requirement has been breached?
A laboratory's proficiency testing report shows one of five HbA1c survey results outside the acceptable range for that event; the other four passed and routine quality control was acceptable throughout. What should the laboratory do first?
Keeping bedside testing under laboratory oversight
Testing done at the bedside still belongs to the laboratory. This area covers the oversight that keeps a ward glucose meter, a blood gas analyser or a urine strip reader producing results a physician can act on. You train and periodically re-assess the nurses and physicians who operate the device, confirm that quality control is run and accepted at the required frequency, watch lot changes and expiry dates, and compare device results against the central laboratory on split specimens. Deficiencies are documented and followed up exactly as they would be for bench work.
Nursing staff on a surgical ward operate the glucose meters, and the meters were supplied and installed by the manufacturer. Under the laboratory's point-of-care testing service, who is accountable for verifying that these operators remain competent?
A blood gas analyser in the emergency department is being monitored under the laboratory's point-of-care programme. Which activity most directly demonstrates that its results agree with those from the central laboratory?
Raising deficiencies instead of quietly fixing them
Laboratories improve only when problems are written down. This area asks you to recognize a deviation from the expected process — a missed critical value call-back, an expired reagent found in use, a fridge log signed for a shift nobody worked — and to enter it in the non-conformance system rather than correct it privately. Near misses count, even when no patient was affected. You describe what happened factually and without blame, and you help identify the underlying cause so that the corrective action addresses the process rather than the individual.
A technologist notices that the reagent fridge temperature log has been signed for two days on which the person who signed it was on leave. Temperatures recorded elsewhere show no excursion and no reagent was affected. What is the appropriate action?
An internal audit finds that critical value call-backs went undocumented on three occasions last month. The same finding was raised a year ago, and the response then was a reminder circulated to all staff. What does an effective corrective action now require?
Keeping logs and control charts that stand up to an audit
Records are the evidence that the work was controlled. Temperature logs, maintenance records, reagent logs and control charts are completed at the time the activity happens, initialled, and kept legible for the full retention period. An error is ruled through once and initialled so the original entry remains readable — never erased, never covered. Control charts carry the mean and standard deviation appropriate to the lot and instrument actually in use, points are plotted promptly, and out-of-range results are annotated with what was done about them. An unrecorded action is treated as an action that never happened.
A technologist writes the wrong figure in the water bath temperature log and notices immediately. How should the entry be corrected in a paper record?
A new lot of quality control material arrives while the current lot is nearly exhausted. How should the laboratory establish the mean and standard deviation to be used on the new lot's control chart?
Judging control and calibration data before results are released
Before any patient result leaves the analyser you decide whether the run was in control. That means reading quality control against defined limits and multirules rather than judging whether a number looks close enough, knowing the difference between a warning that prompts a look and a rule violation that rejects the run, and confirming that the calibration behind the run is current, in date and matched to the reagent lot. It also means recognizing when calibration must be repeated — after major maintenance, a lamp or electrode change, a new reagent lot, or a drift the control data has started to show.
A laboratory applies Westgard multirules to its chemistry controls. In one run a single Level 1 result falls at +2.2 SD, the Level 2 result is within 1 SD, and no other rule is violated. What does this finding signify?
The evening shift replaces the photometric lamp on a chemistry analyser after an intensity alarm. The instrument passes its startup checks. Before patient testing resumes, what is required?
Telling random scatter apart from a systematic drift
Errors come in two shapes and they are handled differently. Random error scatters results on either side of the mean and widens imprecision; an air bubble, a partly blocked probe or an unstable bath temperature typically causes it, and it usually appears as an isolated outlier or a broadening spread. Systematic error moves results in one direction — a shift appearing abruptly after a calibration or lot change, a trend developing as a reagent or lamp deteriorates. Reading control charts for these patterns lets you find and fix the cause before patient results are affected.
Twelve consecutive Level 1 potassium control results all plot above the mean, none of them exceeding +2 SD, on a chart whose limits were established on the current lot. Which conclusion best fits this pattern?
On an otherwise stable analyser, one albumin control result falls at −3.4 SD. The chart shows no shift or trend before it, and an immediate repeat on the same control vial returns a value within 1 SD. Which cause is most consistent with this finding?
Proving a new lot, reagent or analyser before it goes live
Nothing new goes into patient use on the manufacturer's word alone. For a new reagent lot you run the old and new lots in parallel with controls, and ideally with patient specimens spanning the reportable range, to confirm the results agree before the changeover. For an unmodified, approved assay on an additional analyser you verify precision, accuracy against a comparative method or reference material, and the reportable range, and you confirm the reference interval suits your patient population. All of it is documented and signed off before the first patient result is reported.
A new lot of creatinine reagent has arrived and the laboratory intends to place it in service tomorrow morning. What must be done before patient results are reported using it?
A laboratory is bringing an additional chemistry analyser into service for an unmodified, regulator-approved assay that it already performs on an existing instrument. Which set of studies satisfies the verification requirement?
Managing stock so testing never stops mid-shift
Running out of a reagent partway through a shift is a quality failure, not merely an inconvenience. This area covers knowing your usage rate, setting minimum stock levels and reorder points, inspecting deliveries on arrival, and storing each item at the temperature its insert specifies. Stock is rotated so that the earliest expiry is used first, and expired material is removed from the bench rather than left on the shelf beside the current lot. Lot numbers are recorded against the runs they were used for, so that a manufacturer's recall can be traced to the patient results involved.
New boxes of a chemistry reagent arrive carrying an expiry date six months later than the boxes already on the storage shelf, which are still well within date. How should the incoming stock be shelved?
A manufacturer issues an urgent recall on one lot of cardiac troponin reagent because of a positive bias detected after release. Which record allows the laboratory to identify which patient results may have been affected?
Handling laboratory and patient data over its whole life
Laboratory data has to stay accurate, private and retrievable for years. This area covers entering and verifying results correctly, amending a released result so that the original value, the new value, the reason and the person responsible all remain visible, and never overwriting a record silently. It also covers access — you view the results your work requires and no others — together with backup, secure storage, defined retention schedules, and a tested downtime procedure so that results generated while the information system is unavailable are still recorded, traceable and later reconciled with the permanent record.
A verified glucose result has already been released to the ward when the technologist discovers it was reported on the wrong specimen and must be corrected in the laboratory information system. What must the amended record show?
The laboratory information system will be unavailable for four hours during a planned upgrade, and urgent chemistry testing must continue throughout. What must the laboratory have in place so that results generated during this period remain traceable?
Working only from the current controlled version of a procedure
Every laboratory procedure exists in exactly one current, approved version, and that is the one the bench works from. This area covers using documents issued through the controlled system rather than photocopies taped inside cupboard doors, checking that the version in your hand is the current revision, and withdrawing superseded copies as soon as a revision is issued. Changes go through review and authorization before release, staff are informed and trained on them, and obsolete versions are either destroyed or archived and clearly marked so they cannot be picked up and followed by mistake.
A technologist finds a photocopied procedure taped inside a cupboard door at the bench. Comparing it with the document management system shows it is an earlier revision with different centrifugation times. What should be done with the photocopy?
Following a manufacturer's update, the incubation time in an immunoassay procedure is changing from five minutes to ten. Before the bench begins working to the new time, what must happen to the standard operating procedure?
Back to all clinical chemistry areas in the Clinical Chemistry study guide.
MLTPrep is an independent study resource. Not affiliated with or endorsed by CAMLPR. Always confirm current requirements with CAMLPR directly.